Sort
15,842 grants matching “pancreatic cancer”
Gemcitabine-Radiation for Advanced Pancreatic Cancer
$343,925Theodore S Lawrence · University Of Michigan At Ann Arbor · R01 · FY2007 · CA
Gemcitabine-Radiation for Advanced Pancreatic Cancer
$343,925Theodore S Lawrence · University Of Michigan At Ann Arbor · R01 · FY2009 · CA
Gemcitabine-Radiation for Advanced Pancreatic Cancer
$343,925Theodore S Lawrence · University Of Michigan At Ann Arbor · R01 · FY2010 · CA
Phosphorylation-dependent regulation of GLI transcription factors
$343,891Scott Atwood · University Of California-Irvine · R01 · FY2019 · CA
Dissecting Hedgehog, TGF beta and BMP Signaling During Pancreatic Tumorigenesis
$343,867Brian C Lewis · Univ Of Massachusetts Med Sch Worcester · R01 · FY2011 · CA
Role of the BMP SMADs in Oncogenesis
$343,739Stephanie A Pangas · Baylor College Of Medicine · R01 · FY2014 · CA
Heparanase in Tumor Progression, Metastasis and Chemoresistance
$343,602Ralph D Sanderson · University Of Alabama At Birmingham · R01 · FY2019 · CA
Regulation of Exocrine Pancreatic Progenitors by Ptf1a-p48
$343,413Steven D Leach · Johns Hopkins University · R01 · FY2009 · DK
Obesity and Pancreatic Cancer: The Role of IGF-1
$343,390Susan M Fischer · University Of Tx Md Anderson Can Ctr · R01 · FY2009 · CA
Targeting immune stroma interactions in pancreatic cancer
$343,355Gregory B. Lesinski · Emory University · R01 · FY2019 · CA
Nanotechnology enabled targeting of p53 deficiency in human cancer
$343,342Xiaoming He · Univ Of Maryland, College Park · R01 · FY2019 · CA
Targeting transient receptor potential channels to suppress proviral mitochondrial fission and mitophagy in order to mitigate CVB pancreatitis
$343,200Jon Sin · University Of Texas Dallas · R01 · FY2025 · DK
NANOTECH BIOMARKERS FOR RENAL CANCER INTERVENTION: CLINICAL VALIDATION & UTILITY
$343,125Jeremiah J Morrissey · Washington University · R01 · FY2017 · CA
MECHANISMS OF CHIEF CELL DEDIFFERENTIATION
$343,125Jason C Mills · Washington University · R01 · FY2017 · DK
NANOTECH BIOMARKERS FOR RENAL CANCER INTERVENTION: CLINICAL VALIDATION & UTILITY
$343,125Jeremiah J Morrissey · Washington University · R01 · FY2018 · CA
NANOTECH BIOMARKERS FOR RENAL CANCER INTERVENTION: CLINICAL VALIDATION & UTILITY
$343,125Jeremiah J Morrissey · Washington University · R01 · FY2016 · CA
MECHANISMS OF CHIEF CELL DEDIFFERENTIATION
$343,125Jason C Mills · Washington University · R01 · FY2015 · DK
MECHANISMS OF CHIEF CELL DEDIFFERENTIATION
$343,125Jason C Mills · Washington University · R01 · FY2016 · DK
Polymeric Nanomedicines of Small Molecules and miRNA for Treating Pancreatic Canc
$343,092Ram I Mahato · University Of Nebraska Medical Center · R01 · FY2014 · EB
Genomic Clinical Variant Expert Curation Panel for Monogenic Diabetes: A Gateway to Precision Medicine in Diabetes Mellitus
$343,083Toni I. Pollin · University Of Maryland Baltimore · U24 · FY2024 · HD
Genomic Clinical Variant Expert Curation Panel for Monogenic Diabetes: A Gateway to Precision Medicine in Diabetes Mellitus
$343,083Toni I. Pollin · University Of Maryland Baltimore · U24 · FY2025 · HD
Mechanism and Anti-Cancer Activity of SCFA-Hexosamine Analogs
$343,015Kevin J Yarema · Johns Hopkins University · R01 · FY2022 · CA
Mechanisms of durable antitumor immunity via CD26hiCD4+ T cells
$342,972Chrystal Mary Paulos · Medical University Of South Carolina · R01 · FY2018 · CA
ZIP4 is a Novel Molecular Target in Human Pancreatic Cancer
$342,938Min Li · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2018 · CA
ZIP4 is a Novel Molecular Target in Human Pancreatic Cancer
$342,938Min Li · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2017 · CA